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ABSTRACT
ONE-CARBON METABOLISM RELATED B-VITAMINS
ALTER
THE EXPRESSION OF MICRORNAS AND TARGET GENES
WITHIN THE WNT SIGNALING PATHWAY
IN MOUSE COLONIC EPITHELIUM
MAY 2016
RICCARDO RACICOT, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Zhenhua Liu
It has been widely recognized that microRNAs are involved in nearly all cellular processes that
have been investigated and contribute to a variety of diseases including cancer. Our prior studies
demonstrated the depletion of one-carbon metabolism related B-vitamins, including folate,
vitamin B2, B6 and B12, induced a genomic DNA hypomethylation and an elevation of the
tumorigenic Wnt signaling in mouse colonic epithelium. The present study aimed to define
whether microRNAs serve as mediators between these B-vitamins and the Wnt signaling, and
thereby influence intestinal tumorigenesis. MicroRNA expression profiles were measured using
miRNA microarray and real-time PCR on colonic epithelial cells from Apc1638N mice fed with
diets deplete or sufficient in those B-vitamins. In silico bioinformatic analysis were performed to
predict microRNA gene targets within the Wnt signaling cascade. Out of 609 microRNA
examined, 18 microRNAs were found to be either significantly (p < 0.05) or mildly (p < 0.10)
differentially expressed in the colonic epithelium of mice fed the depleted diet when compared to
the counterpart. Bioinformatic prediction of microRNA gene targets identified 40 genes within
the Wnt pathway to have homology with microRNA seed sequences within their 3’-UTR or
iv

protein coding sequence. Of the 6 genes tested for experimentally target validation, the
expression of Sfrp1 was shown to be significantly inhibited (p < 0.05) whereas β-catenin was
shown to be significantly elevated (p < 0.05) with alterations of others in a fashion indicating the
activation of Wnt signaling.

These findings indicate that microRNAs may constitute a

mechanism by which one-carbon B-vitamin depletions regulate the Wnt signaling pathway and
thereby inform intestinal tumorigenesis.
Key words: One-carbon metabolism, microRNA, Wnt pathway, Colorectal cancer
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CHAPTER 1
LITERATURE REVIEW
1.1

microRNA
microRNA (miRNA) are a class of short, non-coding RNA ~18-25 nucleotides in length

which post-transcriptionally regulate mRNA expression in plants, animals and protozoa.
Description of the C. elegans miRNA lin-4 in 1993 was the first characterization of a miRNA,
offering the first insight into the regulatory role of non-coding RNA (Lee 1993). Regulatory
function by miRNA was not described again until 2000 with the discovery of let-7, also in C.
elegans (Reinhart 2000). Both miRNA were found to repress expression of various protein
coding genes through imperfect complimentary basepairing with the 3’ UTR of mRNA (Reinhart
2000).

These studies revealed key functions of miRNA, specifically temporal control of

developmental events by miRNA through the regulation of interdependent genes (Reinhart
2000). Since these findings, identification of miRNA has increased exponentially to over 28,000
mature sequences registered in the miRBase database (www.miRBase.org, access on March 18,
2016), of which 2,588 have been identified in humans and 1,915 in mice. It is predicted that
60% of all protein coding genes in the mammalian genome harbor target site in their 3’UTR for
miRNA binding (Bushati 2007) (Sayed 2011). This ubiquitous nature indicates an important role
for miRNA mediated regulation of cellular processes.
1.1.1 microRNA biogenesis and function
In the nucleus RNA polymerase II generates a primary stem-loop structure (pri-miRNA)
varying in size from a few hundred nucleotides to kilobases in length (Bushati 2007). Once
transcribed, pri-miRNA are processed in the nucleus by a protein complex known as the
microprocessor. The microprocessor consists of the RNase III, DROSHA, and doublestranded
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RNA binding domain (dsRBD) protein DGCR8 dimer. DROSHA recognizes and binds the
ssRNA-dsRNA junction of pri-miRNA and uses this site as a molecular ruler to identify the
cleavage site ~11 base pairs from the ssRNA-dsRNA junction. DGCR8 plays three distinct roles
in pri-miRNA processing: binding and stabilization of the C-terminal tail, recruitment of the primiRNA via the dsRBD and recognition of the apical UGU motif (Nguyen 2015). Once the primiRNA is bound and oriented, DROSHA cleaves the pri-miRNA at the cleavage site (Han
2006), producing a ~70 bp hairpin loop structure known as the precursor-miRNA (pre-miRNA)
with a 3’ 2 nucleotide overhang characteristic of RNase III mediated cleavage (Lee 2003). The 2
nucleotide overhang is subsequently recognized by the transport molecule Exportin5, (Yi 2003)
which shuttles the pre-miRNA to the cytoplasm for additional processing via a Ran-GTP
dependent mechanism (Bohnsack 2004)
In the cytoplasm, the RNase III Dicer anchors both the 3’ and 5’ end of the pre-miRNA
and determines the cleavage site using the 5’ counting rule. Dicer identifies the 5’ phosphate cap
and “measures” ~22 nucleotides from the 5’ terminal end of the pre-miRNA then cleaves both
strands at this site, producing a small RNA duplex (Park 2011). The RNA duplex is actively
loaded onto argonaute (AGO) and unwound. Duplex unwinding then typically occurs in an ATPindependent manner. The current “rubber band” model suggests structural tension is applied in
the open confirmation of AGO. Upon release tension is relieved, inducing duplex unwinding
(Kawamata 2010). The strand not bound to AGO, termed the passenger strand, is then released
and degraded (Matranga 2005).
The remaining strand bound to AGO, termed the guide strand, has a complimentary
sequence to its target mRNA and maintains a conformation preferential for target binding (Czech
2009). The guide strand then directs the miRNA-induced silencing complex (miRISC), which is
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comprised up of AGO and glycine-tryptophan repeat–containing protein (GW182), to gene
targets (Bushati 2007). Upon engaging the target mRNA AGO will take an open conformation,
exposing bases 2-7 of the guide miRNA, termed the seed region, to face outward and allow for
efficient recognition and base pairing to the target (Gan 2015).
Depending on the degree of complementarity between the target and the guide, miRNA
employ multiple mechanisms which result in the suppression of gene expression (Hutvagner
2002) (Martinez 2004). If base pairing complementarity is near perfect, hydrolysis of the target is
induced by AGO, leading to mRNA degradation by cellular exonucleases (Hutvagner 2002).
Hydrolysis is mediated by only one isoform, AGO2 as it is the only catalytically active AGO in
humans (Cheloufi 2010). Cleavage of phosphodiester bonds occurs between the target bases
paired with bases 10 and 11 of the guide miRNA (Elbashir 2001). The two product fragments
exposed to degradation by the SKI complex and 5’-3’ exoribonuclease 1 or 2 (XRN1, XRN2)
(Chatterjee 2011).
Non-cleavage translational repression of target genes only requires complementarity with
the miRNA seed region (Filipowicz 2008). This allows miRNA to target and effectively suppress
as many as 100-200 targets according to computational estimates (Krek 2005) (Lim 2005).
Multiple in vitro models of translational repression have been proposed including cotranslational
protein degradation (Nottrott 2006), inhibition of translation elongation (Gu 2009), ribosome
drop-off leading to premature termination of translation (Petersen 2006), inhibition of translation
initiation through interference of ribosome recruitment (Mathonnet 2007), sequestering of
mRNAs in processing bodies (P bodies) void of ribosomes (Ding 2007), prevention of
circularization (Zekri 2009), and deadenylation followed by decapping and subsequent
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degradation (Chen 2009). Despite the success of in vitro studies, it is unknown whether there is
a primary mechanism or multiple mechanisms working in tandem in vivo.
1.1.2 microRNA in cancer development
miRNA activity has been observed in nearly all cellular processes including
development, metabolism, cell differentiation, proliferation and apoptosis. In accordance with
their ubiquitous nature, miRNA activity has been linked 163 different diseases, and play a
prominent role in colorectal cancerogenesis (Jiang 2009). In cancer, miRNA may act as either
oncogenes by downregulating tumor suppressor genes or conversely act as tumor suppressors by
downregulating oncogenes (Luo 2011).
Differential miRNA expression in cancer cells and tissues versus adjacent normal tissue
using microarrays is a method commonly used to establish cancer related miRNA profiles and
has been utilized to create a miRNA expression profile in human CRC tissue (Schetter 2013). Of
164 significantly altered miRNA in CRC, 2/3 demonstrate increased expression while the
remaining 1/3 demonstrate decreased expression. This variance in expression indicates a favor
towards oncogenic function of miRNA (Luo 2011). Here we highlight the current literature
demonstrating both tumor suppressive and oncogenic roles of miRNA in cancerogenesis with a
focus on CRC when possible.
1.1.2.1 Tumor Suppressor miRNA
Increased expression of the miR-30 family has been shown to act as a tumor suppressor
in humans. Tumor suppressive activity has been suggested by significant downregulation of
miR-30 family miRNA, with concurrent increased expression of epithelial to mesenchymal
(EMT) genes in human pancreatic islet cells (Joglekar 2009), prostate cells (Kao 2014) and
hepatocytes (Budhu 2008) (Zhang 2012). A tumor suppressive role is attributed to targeting of
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EMT genes such as vimentin and SNAIL which share the complementarity with the miR-30 seed
sequence (Joglekar 2009). In addition, miR-30 has been shown to reduce stem-like features in
tumor-initiating breast cells through targeting ubiquitin-conjugating enzyme 9 (Ubc9) and
Integrin β3 (ITGB3) (Yu 2010).
Tumor suppressive activity of miR-146a has been demonstrated in multiple cancer types
including oral (Scapoli 2010), prostate (Lin 2008), breast (Bhaumik 2008), pancreatic (Li 2010),
gastric (Kogo 2011) and colorectal (Mao 2014) cancers. CRC tissue (Mao 2014) and stool
samples both exhibit downregulation of miR-146 (Ahmed 2013), suggesting a tumor suppressive
role in the disease. miR-146 likely plays a role in suppression of metastasis as it targets
SMAD4, a protein which is typically lost in CRC and is associated with EMT (Zhong 2010).
Further, miR-146a expression levels have been shown to be decreased in metastatic tumor tissue
when compared to primary tumor tissue (Pizzini 2013).
To date, only one study has assessed the role of miR-361-5p in CRC. This initial data
suggests a tumor suppressive role as expression was decreased in CRC when compared to
normal tissue and overexpression inhibited invasion and metastasis (Ma 2015).Tumor
suppressive action occurs through targeting of staphylococcal nuclease domain containing-1
(SND1), which has been shown to have an oncogenic effect in CRC by downregulating APC
(Tsuchida 2011). Interplay between miR-361-5p and SND1 acts as a feedback loop, as miR361-5p represses SND1 expression through binding of 3’-UTR while SND1 was found to bind to
pre-miR-361-5p and negatively regulating its expression (Ma 2015).
The role of miR-409-3p expression in cancer appears to be tissue specific. A tumor
suppressive effect on lung adenocarcinoma (Wan 2014), bladder cancer (Xu 2013b) and CRC
(Bai 2015) (Liu 2015) has been demonstrated. However, miR-409-3p has an oncogenic effect in
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prostate cancer (Josson 2014). Currently, only two studies have been performed in an attempt to
elucidate the role of miR-409-3p in CRC (Bai 2015) (Liu 2015). Neither study has provided a
clear picture as to gene targets implicated in the tumor suppressive role of miR-409-3p in CRC.
The serine/threonine kinase NLK has been verified by Liu et al as a target of miR-409-3p (Liu
2015). Other studies have shown NLK is a mediator of Wnt signaling through phosphorylation
of TCF/LEF (Ishitani 1999). Bai et al have identified Grb2-associtated binder 1 (GAB1) as a
target of miR-409-3p (Bai 2015). GAB1 is a scaffolding adapter protein which mediates cell
growth and differentiation and has been implicated in tumor progression in CRC (Seiden-Long
2008). Overexpression of miR-409-3p was shown to successfully downregulate GAB1 and
suppress invasion both in vitro and in vivo (Bai 2015).
The major product of stem-loop mir-139 is miR-139-5p and as such there are significant
insights into its function, including downregulation and a tumor suppressive role in CRC (Shen
2012). The minor product, miR-139-3p, has been studies less extensively. However, Liu et al
have assessed the effect of miR-139-3p on CRC tissue from 63 patients with pathologically
diagnosed primary colon cancer (Liu 2014a). miR-139-3p levels were found to be inversely
associated with survival as patients with high expression of miR-139-3p had a significantly
longer survival time compared with those with low expression (Liu 2014a). The results of this
study are limited due to sample size and only assessed miR-139-3p as a diagnostic marker,
providing no insight into its molecular role or targets (Liu 2014a). To date no gene targets for
miR-139-3p have been validated in CRC tissue (Vlachos 2015).
Downregulation of miR-125a-5p has been demonstrated in breast (Guo 2009) (O’Day 2010),
ovarian (Nam 2008), lung (Wang 2009b), gastric (Nishida 2011), medulloblastoma (Ferretti
2009) and colorectal cancer (Tong 2015) tissues. Recently Tong et al demonstrated

6

downregulation of miR-125a-5p in CRC tissues and cell lines and validated anti-apoptotic gene
targets Bcl-2, BCL2L12 and MCL1 (Tong 2015). This study also showed an induction of
apoptosis and inhibition of cell proliferation as a result of miR-125a-5p overexpression (Tong
2015).
1.1.2.2 Oncogenic miRNA
miR-31-5p displays complex expression patterns in human cancers, exhibiting both
oncogenic and tumor suppressive roles in disease development (Xu 2013a). In melanoma, breast
and prostate cancer miR-31-5p is regularly down-regulated. In contrast it is upregulated in lung,
oral and colorectal cancers (Xu 2013a). Overexpression of miR-31-5p has been observed in CRC
primary tumors isolated from all clinical stages of primary tumors as well as in cell lines
(Bandrés 2006) (Wang 2009a) (Cekaite 2012) (Shee 2012) (Sun 2013) (Xu 2013a). High
expression levels of miR-31-5p have been associated with advanced tumor stage and poor
differentiation in CRC (Schee 2012). In addition, miR-31-5p expression levels have been shown
to be elevated in premalignant polyps, indicating a role in early cancer development (Cekaite
2012).
Important targets for mir-31-5p in CRC development are the tumor suppressive GTPases
RhoBTB1 and RASA1 (Xu 2013a) (Sun 2013) as well as TIAM1, a guanidine exchange factor
of the Rac GTPase (Cottonham 2010). miR-31-5p is also associated with mutations in the protooncogenic gene BRAF in CRC tissue (Nosho 2014) (Ito 2014). BRAF mutations are linked to
CpG island methylator phenotype (CIMP) which is defined as widespread CpG island promoter
methylation, typically in DNA repair and tumor suppressor genes (Mojarad 2013) and has been
correlated with increased expression of DNA methyltransferase 1 (Etoh 2004).

7

Oncogenic behavior of miR-27a-3p has been observed in multiple cancer types including
breast (Guttilla 2009), gastric (Liu 2009) and kidney (Chow 2010). The relationship between
miR-27a and CRC however has yet to be established. To date, one study has demonstrated tumor
suppressive action in CRC (Bao 2014). The role of miR-27a in CRC is further complicated by
the occurrence of two natural genetic variants of the miRNA (Wang 2014b). An A/G single
nucleotide polymorphism (SNP) rs895819 in miR-27a appears to be associated with CRC
susceptibility in ethnic Han Chinese (Cao 2014) (Wang 2014b). Wang et al was only able to
show an association between the GG genotype (Wang 2014b) while Cao et al demonstrated an
association between both the GG and AG genotypes and CRC (Cao 2014). Cao et al also
observed increased relative expression of miR-27a in tumor tissues from those with the GG
genotype and in those carrying at least one G allele when compared to tumors from AA patients,
indicating an oncogenic role (Cao 2014).
miR-92a and miR-92b belong to the miR-92 family a member of the polycistronic mir17–92 cluster (Olive 2010). The mir-17-92 cluster was the first non-coding RNA to be described
as an oncogene (He 2005) and consists of four miRNA families: the miR-17, miR-18, miR-19
and miR-92 families (Olive 2010). He et al demonstrated overexpression of mir-17-92 in
conjunction with overexpression of Myc, a known oncogene, increased the rate of development
of malignant lymphomas when compared to overexpression of Myc alone (He 2005). However,
overexpression of Myc along with individual miRNAs of the mir-17-92 cluster did not result in
accelerated onset of disease (He 2005). The mir-17-92 cluster has also been implicated in
hepatocellular carcinoma (Connolly 2008), medulloblastoma (Northcott 2009), leukemia (Li
2012b), lung cancer (Hayashita 2005) and CRC (Nishida 2012).
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Mature sequence miR-92a has been determined to be a key oncogenic component of the
mir-17-92 cluster in the development of CRC (Tsuchida 2011). In both CRC adenomas and
carcinomas mir-92a is transcribed at a higher rate than any other miRNA transcribed in the mir17-92 cluster and directly targets the pro-apoptotic tumor suppressor BCL-2-interacting mediator
of cell death (BIM) (Tsuchidad 2011). Relative expression levels of miR-92a have been shown
to be significantly elevated in CRC tissues when compared to normal adjacent mucosa (Zhou
2013). Elevated expression of miR-92a has also been correlated with advanced clinical stage,
lymph node metastases, distant metastases, while increased expression is an independent
predictor of overall survival (Zhou 2013).
To date miR-92b has been implicated in few malignancies; non-small cell lung cancer
(Lei 2014), mantle cell lymphoma (Pal 2007) and Glioma (Li 2013). miR-92b levels are
significantly elevated in high-grade gliomas compared with low-grade gliomas while
overexpression has been shown to increase cell proliferation (Li 2013). Increased cell
proliferation has been demonstrated to be regulated through modulation of the Wnt pathway,
specifically by direct targeting and downregulation of the Wnt antagonist Dickkopf-3 (DKK3) (Li
2013).
Initially implicated in glioblastoma over a decade ago miR-21 is one of the earliest and
most highly studied oncogenic miRNA (Chan 2005). Early evaluation of miRNA expression
signatures in solid tumor tissues reported overexpression of miR-21 in all six tissue types
considered; breast, CRC, lung, pancreas, prostate, stomach (Volinia 2006). Since these findings,
overexpression of miR-21 has been reported in head and neck (Chang 2008), ovarian (Nam
2008) and esophageal cancers (Mathé 2009), leukemia (Fulci 2007), lymphoma (Lawrie 2007),

9

multiple myeloma (Pichiorri 2008), osteosarcoma (Ziyan 2011), and spermatocytic seminoma
(Gillis 2007).
miR-21 expression levels have been established as a reliable prognostic marker (KjaerFrifeldt 2012) (Zhang 2013) and a significant predictor of survival (Nielsen 2011) in patients
with stage II CRC. miR-21 has multiple validated tumor suppressor gene targets in CRC
including programmed cell death 4 (PDCD4) (Asangani 2008), transforming growth factor beta
receptor 2 (TGFβR2) (Yu 2012), Cell division cycle 25A (Cdc25A) (Wang 2009c) Integrin-β4
(ITGβ4) (Ferraro 2014) and, along with miR-31, TIAM1 (Cottonham 2010). Modulation of the
Wnt pathway by miR-21 may play a role in CRC as Yu et al demonstrated a 60% reduction in
Axin expression and increased expression of total β-catenin, c-Myc and cyclin-D1 in HCT-116
cells overexpressing miR-21 (Yu 2012).

1.2

Colorectal Cancer and the Wnt pathway

1.2.1 Colorectal cancer incidence and mortality
Traditionally, CRC is divided into three patterns: sporadic, familial or inherited cases. 7580% of CRC cases are considered sporadic, due to an apparent absence of familial history, while
familial cases account for 20-25%, with the remaining 5-10% made up of inherited hereditary
diseases (Amersi 2005). Significant familial history is defined: “if two or more first-degree
relatives have been diagnosed with colon cancer or colon polyps at any age or if a first-degree
relative has been diagnosed with colon cancer or colon polyps before the age of 60” (Amersi
2005). Inherited cases of CRC are the result of either hereditary polyposis or nonpolyposis
syndromes (Haggar 2009).
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1.2.1.1 Incidence
Worldwide, Colorectal Cancer (CRC) is the third most common cancer in both men and
women, accounting for 10% of all cancer incidences (Stewart 2014). Since the 1980s, incidence
of CRC in the United States has been rapidly declining likely due to improved screening
methods leading to increased detection (Jemal 2011). This has led to an average decline in
incidence of 3.4% per year between 2001 and 2010 in the US (Siegel 2014). Despite the
improvement of incidence rates in the United States, as well as other Western countries, areas
previously thought of as low-risk for CRC are showing drastic increases in incidence rates.
Spain, Singapore and Israel have shown significant increases in recent years while Japan and the
Czech Republic have now surpassed the peak incidence rates of the United States (Center 2010).
This increased incidence is believed to be due to the spread of Western culture, defined as a lack
of physical activity, increased intake of calorie-dense foods and increased prevalence of smoking
(Center 2010).
1.2.1.2 Mortality
In the United States, CRC is the third most common cancer and the third leading cause of
cancer death, resulting the death of an estimated 26,270 men and 24,040 women in 2014 (Siegel
2014). However, mortality rates in the United States are decreasing at an increasing rate.
Throughout the 1990s mortality decreased at an average rate of 2% per year, compared to an
average of 3% between 2001 and 2010 (Howlander 2015). This decrease in mortality has been
attributed to improved pattern changes in risk factors, treatment and screening (Edwards 2010).
Improvements in screening have been vital to this decrease, accounting for 53% while changes in
risk factor patterns and treatment account for 35% and 12%, respectively (Edwards 2010). As
CRC progresses, five-year survival decreases. Diagnosis while the disease is in the localized
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stage leads to a five-year survival of 90%. This rate decreases to 68% when the disease
progresses to the regional stage and drastically decreases to 10% when distant metastasis occurs
(Howlander 2015). This disparity in five-year survival demonstrates the importance of screening
for early diagnosis, resulting in improved survival outcomes.
1.2.1.3 Colorectal cancer and Wnt signaling
Intestinal epithelium is the most rapidly self-renewing tissue in adult mammals with a
turnover occurring every 5-7 days in the colon (Barker 2014). Regenerative capacity of the adult
epithelium is regulated by Wnt signaling driven stem cell renewal (Barker 2014). Consequently,
an important mechanistic role for Wnt signaling has been recognized in the development of CRC
(Barker 2014). Over 90% of colon cancers possess activating mutations within the Wnt pathway
(Fodde 2001). A variety of mutational and epigenetic silencing events within the Wnt pathway
have been classified, most of which abrogate APC function (Moser 1993) (Jasperson 2014).
1.2.2 The tumorigenic Wnt pathway
The Wnt signaling pathway is an evolutionarily conserved pathway which regulates cellcell interactions in embryonic development, adult tissue regeneration, homeostasis and stem cell
maintenance (Clevers 2006). The Wnt signaling pathway is a group of signal transduction
pathways consisting of proteins that pass signals into a cell. The Wnt pathway is activated by
binding a Wnt protein ligand to a Frizzled family receptor, which passes the biological signal to
the protein dishevelled inside the cell (Nusse 1992). Wnt signaling is partitioned into
subpathways: the canonical and noncanonical pathways. The canonical Wnt pathway is
dependent on β-catenin, leading to regulation of gene transcription, whereas the noncanonical
Wnt pathways are not dependent on β-catenin. There are two major noncanonical Wnt pathways:
the planar cell polarity (PCP) pathway regulates the cytoskeleton that is responsible for the shape
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of the cell and the noncanonical calcium pathway regulates calcium inside the cell (Rao 2010).
The canonical Wnt signaling has been highly researched and plays significant role in cancer
development (Clevers 2006) and will thus be the primary focus of this work.
1.2.2.1 Wnt Ligands
Individual discoveries in different species initially characterized Wnt genes as the
segment polarity gene Wingless (wg) in Drosophila (Nusslein-Volhard 1980) and the mouse
proto-oncogene integrated (Int-1) (Nusse 1982). Subsequent analysis determined Int-1 and wg to
be homologous, forging an interrelation between oncogenic and developmental processes
(Rijsewijk 1987).
Wnt genes are expressed in all metazoan species and genomic analysis has revealed 19
Wnt genes in human and mouse, 7 in Drosophila, and 5 in C. elegans (Nusse 2005). Human Wnt
proteins are defined by gene sequence rather than function, sharing an average of 35% amino
acid sequence identity and a conserved pattern of 23 or 24 cysteine residues (Logan 2004). All
cysteine residues are believed to occupy intramolecular disulfide bridges providing the protein
with a globular structure and characteristic hydrophobicity (Janda 2012).

1.2.2.2 Wnt Antagonists
Several secreted proteins bind Wnt in the extracellular matrix acting as antagonist for Wnt
signaling (Cruciat 2012). Overall, small protein antagonists prevent ligand–receptor interactions
or Wnt receptor maturation (Cruciat 2012). Two mechanisms for protein mediated inhibition
seem to exist; binding to the Wnt co-receptor LRP6 and direct binding of, and sequestering Wnt
proteins. Dickkopf proteins (Dkks) (Glinka 1998), Wise/SOST (Semenov 2005) and insulin-like
growth-factor binding protein 4 (IGFBP-4) (Zhu 2008) are the known proteins families which act
13

as Wnt antagonists through indirect inhibition. The inhibitors Secreted Frizzled-related proteins
(sFRPs) (Leyns 1997), Wnt-inhibitory factor 1 (WIF-1) (Hsieh 1999) and klotho (Liu 2007b)
function through direct binding of Wnt proteins.
The Dkk family includes four proteins: Dkk1/2/3/4, with Dkk1, Dkk2 and Dkk4 playing
a role in the regulation of Wnt signaling (Cruciat 2012). The mechanism of action for Dkk1/2
involves high affinity binding to the Wnt coreceptor low-density lipoprotein receptor-related
protein (LRP) 5/6 resulting in the inhibition of Wnt ligand binding (Niehrs 2001). The cystine
knot–containing protein Wise/SOST has been proposed to act through similar mechanism as
Dkk1/2, binding to the first two YWTD–EGF repeat domains of LRP5/6, modulating Wnt
signaling in a cell context-dependent manner (Semenov 2005). IGFBP-4 abrogates Wnt signaling
through direct binding of the conserved carboxy-terminal thyroglobulin domain to either of the
Wnt coreceptors LRP6 or Frz8 (Zhu 2008).
SFRP proteins represent the largest family of secreted Wnt inhibitors, comprising of five
members: sFRP1/2/3/4/5 (Cruciat 2012). sFRP3 was first identified as Frzb (Frizzled motif
associated with bone development), as it shares homology with the N-terminal cysteine rich
domain of the transmembrane Wnt receptor Frizzled (Fzd) (Hoang 1996). Shortly after its
identification, sFRP3 was found to be a an inhibitor of Wnt signaling (Leyns 1997). This initial
work along with others demonstrated Wnt binding to sFRP3 resulting in sequester of Wnt
proteins and subsequent abrogation of signaling (Leyns 1997) (Wang 1997). The conserved
cysteine rich domain in the N-terminal motif of Fzd has been proposed as the Wnt ligand binding
domain (Bhanot 1996) as it has been shown to be necessary and sufficient for sFRP-mediated
inhibition of Wnt signaling (Lin 1997). An alternative mode of action for sFRP-mediated
inhibition has also been proposed as sFRP and Fzd have been shown to dimerize via the cysteine
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rich domain (Bafico 1999), a finding supported by crystal structures of the cysteine rich domains
from mouse Fz8 and sFRP3 (Dann 2001).
Overall, the mechanisms by which Wnt signaling is regulated in the extracellular
environment have yet to be fully elucidated but appear to occur through a variety of mechanisms
including the sequestering of Wnt proteins and binding of Wnt receptors. Further investigation of
these agonists and antagonists will provide significant insights into the role of extracellular
regulation of Wnt signaling.
1.2.2.3 Post Transcriptional Modification
Post transcriptional modification, particularly acylation and glycosylation, has been
shown to be essential for of Wnt protein function (Willert 2012). Glycosylation sites are variable
in Wnt proteins in location and number (Ching 2008). Mutagenesis of glycosylated residues of
Wnt3a (Komekado 2007) and Wnt5a (Kurayoshi 2007) limited their secretion, suggesting
glycosylation likely plays a role in protein folding and secretion. However, this effect is not
strongly observed in Wnt1 (Mason 1992). Glycosylation of Wnt is likely a precursor to acylation
as it has been shown nonglycosylated Wnt3a is not acylated and therefore not secreted
(Komekado 2007).
1.2.2.4 Canonical Wnt Signaling
In the absence of Wnt ligand binding to Fzd/LRP5/6, β-catenin is targeted for degradation
(Li 2012a). In the cell, β-catenin is typically associated with the C-terminal tail of the
transmembrane cell adhesion molecule E-cadherin (McCrea, 1995). Free cytoplasmic β-catenin
is recognized and degraded by a muliprotein Axin destruction complex consisting of Axin, APC,
GSK3β, Dvl, CK1α, βTrCP, and the proteasome (Li 2012a). Axin acts as the central scaffold of
the destruction complex, directly interacting with all other core components (Liu 2002). Inside
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the destruction complex, β-catenin is phosphorylated by the serine/threonine kinase casein kinase
1α (CK1α) on S45 (Liu 2002). Phosphorylation of this residue is a primer necessary for
subsequent phosphorylation of T41, S37 and S33 by glycogen synthase kinase 3β (GSK3β) (Liu
2002). Phosphorylated β-catenin is recognized by the E3 ubiquitin ligase constituent F-box
protein β-TrCP (Hart 1999) leading to ubiquitination (Aberle 1997). Upon ubiquitination βcatenin is released from the Axin complex and degraded by the proteasome, allowing for reuse of
the destruction complex (Li 2012a).
Activation of Wnt signaling through Wnt ligand binding of Fzd/LRP5/6 results in the
stabilization of cytoplasmic β-catenin and transduction of the Wnt signal (Clevers 2006). Binding
of the Wnt ligand to LRP5/6 induces phosphorylation of five PPPSPxS motif (proline, serine or
threonine, x, a variable residue) repeats by GSK3β (Zeng 2005) and CK1γ (Davidson 2005).
Phosphorylation of the PPPSPxS motifs signals for sequestration of Axin (He 2004) which is
recruited to LRP5/6 in the presence of a Wnt signal (Mao 2001). Sequestration of Axin to the
membrane reduces the availability of cytoplasmic destruction complexes, resulting in β-catenin
accumulation (Li 2012a). Upon stabilization and cytoplasmic accumulation, β-catenin
translocates to the nucleus, activating TCF/LEF transcription factors (Molenaar 1996) (Behrens
et al., 1996) and downstream Wnt target genes such as c-Myc (He 1998), cyclin-D1 (Tetsu 1999)
and c-Jun (Mann 1999)
1.2.3 Colorectal Cancer, One-Carbon Metabolism and Wnt signaling
1.2.3.1 One-Carbon Metabolism
One-carbon metabolism (OCM) is a set of reactions involving B vitamins riboflavin, B6,
B12 and folate coenzymes (Ulrey 2005). One-carbon vitamins act as essential cofactors in
nucleotide synthesis (Kim 2000) and the epigenetic process of biological methylation (Pufulete

16

2003). Epidemiologic observations as well as preclinical studies suggest that diminished folate
status increases the risk of colorectal carcinogenesis (Giovannucci 2002) (Choi 2000). Folate
plays an essential role in methylation by remethylation of homocysteine to methionine, the
precursor of S-adenosylmethionine, the universal methyl donor for biological methylation
(Selhub 2002). The reactions by which this occur are dependent on other one-carbon vitamins;
riboflavin, B12 and B6 acting as cofactors (Ulrey 2005).
One-carbon vitamins also assume critical roles as cofactors in the synthesis of
nucleotides: riboflavin is a precursor for the cofactor of methylenetetrahydrofolate reductase,
which catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate
(Van den Veyver 2002); vitamin B12 is a cofactor for methionine synthase, a reaction in which
5-methyltetrahydrofolate participates as a substrate in the remethylation of homocysteine to form
methionine (van den Veyver 2002); and vitamin B6 is a necessary cofactor for the interconversion of other coenzymatic forms of folate and the metabolism of homocysteine (Davis
2004). Therefore metabolic functions of all these one-carbon vitamins are highly interdependent, as depletion of one may lead to biochemical phenotypes characteristic of deficiencies
of the others.
1.2.3.2 One-Carbon Metabolism and Wnt Signaling
Aberrant DNA methylation and DNA synthesis are among the most common molecular
alterations that contribute to the development of human neoplasia (Jones 2002). Specifically in
CRC, de novo methylation of the APC promoter region also plays an important role as a ‘‘second
hit’’ in silencing APC expression in colorectal neoplasia (Arnold 2004). Our group has
previously reported APC expression is also impaired by a severe degree of folate depletion: after
5 weeks of depletion, strand breaks appeared in APC gene and these breaks were inversely
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correlated to steady-state transcriptional levels of APC (Liu 2007a).We have further
demonstrated mild depletion of one-carbon vitamins over 16 weeks increased both macroscopic
tumor multiplicity and aberrant crypt foci by 50%, a 4-fold increase in Wnt signaling and
changes in expression of Wnt signaling genes (Liu 2011). Thus, there is evidence that Wnt
signaling could be altered by dietary inadequacy of one-carbon vitamins and play a role in
colorectal tumorigenesis.

1.3 microRNA and the Regulation of Wnt Signaling
The role of miRNA in regulating Wnt signaling in specific cell and tissue types has yet to
be firmly defined. Research has been non-contiguous and does not present a clear perspective.
Anton et al have performed a systematic screen for miRNA regulating the canonical Wnt
pathway in HEK293 cells and observed differential expression of 38 miRNA (Anton 2010).
Other insights into the regulation of Wnt pathway genes by miRNA have been published which
implicate a role in cancer (Nagel 2008) (Saydam 2009) (Gokhale 2010) (Haug 2011) (Kim
2013).
The effect of the miR-34 family expression on Wnt signaling has been studied in the most
depth (Kim 2011) (Cha 2012) (Kim 2013). miR-34 has effectively married the tumor suppressor
p53 and Wnt signaling pathway (Kim 2011) miR-34 is a transcriptional target of P53 and targets
highly conserved sites in the UTR of Wnt genes;WNT3, LRP6, AXIN2, β-catenin, LEF1 (Kim
2011). This results in suppression of TCF/LEF transcriptional activity, downregulating Wnt
signaling related gene expression (Kim 2011). This effect has been demonstrated in breast, lung
and colon cancer (Kim 2011). Specifically in CRC, expression of miR-34 suppresses Axin2
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through binding at multiple 5′ and 3′ UTR sites, resulting in increased nuclear GSK-3β and
decreased expression of the EMT regulator Snail (Kim 2013).
Other miRNA that have shown tumor suppressive action through the regulation of Wnt
signaling including miR-144 in bladder cancer (Guo 2013) and miR-200a in meningiomas
(Saydam 2009). miR-144 has been demonstrated to have decreased expression in bladder cancer
cell lines and tissues (Guo 2013). This allows for expression of the gene target enhancer of zeste
homolog 2 (EZH2), inactivating Wnt signaling and subsequent cell proliferation (Guo 2013). The
miRNA expression profile brain cancer meningiomas shows downregulation of miR-200a
(Saydam 2009). miR-200a directly targets and downregulates β-catenin mRNA and protein
levels and downstream downregulation of cyclin D1 (Saydam 2009).
Tumor suppressive actions of miRNA in Wnt signaling are not exclusive as two miRNA,
miR-135a/b (Nagel 2008) and miR-92a/b (Haug 2011), have been shown to play an oncogenic
role. Upregulation of miR-135a/b was found in colorectal adenomas and carcinomas resulting in
downregulation of APC (Nagel 2008). miR-135a/b targets the 3′ UTR of APC, suppressing its
expression and enhancing Wnt activity (Nagel 2008). Targeting and downregulation of APC by
miR-135a/b was found to be successful regardless of the mutational status of APC (Nagel 2008).
In neuroblastoma, miR-92a/b was found to downregulate the tumor suppressive Wnt antagonist
DKK3 via binding target sites on the 3’ UTR (Haug 2011).

1.4 Nutritional regulation of microRNA in Cancer Development
Accumulating studies have reported regulation of miRNA expression by dietary factors.
The focus of these studies has largely been the effect of essential nutrients and bioactive dietary
compounds, such as those found in green tea, berries and turmeric in cancer development. The
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results of these studies demonstrate the ability of dietary components to regulate the expression
of miRNA which target epigenetic mechanisms and play a role in downstream gene regulation.

1.4.1 Essential Nutrients: Vitamin D and retinoic acid
1.4.1.1 Vitamin D
The active metabolite of vitamin D, 1α,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is a
major cancer chemopreventive agent which acts through the induction of cell cycle arrest
(Studzinski 1985). Exogenous 1,25(OH)2D3 has been studied for its effect on the mediation of
miRNA expression in various cancer cell lines and has shown success in mediating
cancerogenesis (Mohri 2009) (Giangreco 2013) (Wang 2009d) (Padi 2013) (Chang 2015) (Ma
2014).
Mohri et al have investigated the biological effects of 1,25(OH)2D3 binding to the vitamin
D receptor (VDR) in cancer cell lines as previous data had shown gradual increase in VDR
mRNA and protein expression levels in parallel with ongoing dedifferentiation in the early
phase of cancerogenesis, yet the VDR mRNA decreases to lower levels in late stage carcinomas
(Cross 2001). These findings indicated post-transcription regulation of VDR (Mohri 2009).
Indeed, this work identified a target sequence for miR-125b in the 3’-UTR of human VDR
mRNA and verified targeting of this sequence using luciferase assay in ovarian granulosa-like
tumor cell line KGN and breast cancer cell line MCF-7 (Mohri 2009). Treatment of MCF-7 cells
with 1,25(OH)2D3 resulted in significant upregulation of VDR target genes which were markedly
attenuated through overexpression of miR-125b (Mohri 2009). 1,25(OH)2D3 treatment
demonstrated an antiproliferative effect in MCF-7 cells which was abrogated through
overexpression of miR-125b (Mohri 2009). This study confirmed posttranscriptional modulation
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of VDR through miRNA targeting and demonstrates a diminutive role of miR-125b on the
antiproliferative effect of 1,25(OH)2D3.
miR-125b, along with miR-100 expression have also been shown to be modulated by
1,25(OH)2D3 treatment in pancreatic cancer cells (Giangreco 2013). Expression levels of both
miR-125b and miR-100 were markedly reduced in both tumor tissues and primary prostate
cancer cells when compared to benign tissues and cells, respectively (Giangreco 2013).
1,25(OH)2D3

treatment mediated upregulation of miR-125b and miR-100 and was VDR

dependent (Giangreco 2013). Cancer invasiveness decreased with transfection of pre-miR-125b
and pre-miR-100 in the absence of 1,25(OH)2D3 and was further reduced in 1,25(OH)2D3 treated
cells (Giangreco 2013).
In HL60 leukemia cells 1,25(OH)2D3 treatment has been shown to decrease the
expression of miR-181a and miR-181b in a concentration and time-dependent manner (Wang
2009d). 1,25(OH)2D3 treatment of HL60 cells induced G1 cell cycle arrest, downregulation of
miR-181a and miR-181b and increased expression of tumor suppressive Cyclin-dependent
kinase inhibitor 1B (p27Kip1), a cell cycle inhibitor (Wang 2009d). Transfection of pre-miR-181a
abrogated of 1,25(OH)2D3 induced expression of p27Kip1 and reduced G1 cell cycle arrest in
HL60 cells (Wang 2009d). This suggests a role for miR-181 in cell cycle regulation which may
be modulated by 1,25(OH)2D3.
Evaluation of CRC cells have shown induction of miR-22 by 1,25(OH)2D3 treatment in a
time-, dose- and VDR-dependent manner (Alvarez-Diaz 2012). Induction of miR-22 may be vital
for the effectiveness of 1,25(OH)2D3, as miR-22 loss-of-function by transfection of a miR-22
inhibitor (anti-miR-22) suppresses the antiproliferative effect and increased cell migration of
HCT-116 and SW480-ADH cells (Alvarez-Diaz 2012). Further, transfection of anti-miR-22
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resulted in increased expression of oncogenes NELL2, OGN, HNRPH1, RERE and NFAT5
(Alvarez-Diaz 2012).
miR-627 expression has also been shown to be upregulated in 1,25(OH)2D3 treated CRC
cells (Padi 2013). Treatment with 1,25(OH)2D3 resulted in increased cell doubling time by three
hours (Padi 2013). To confirm miR-627 plays a role in 1,25(OH)2D3 mediated inhibition of cell
proliferation, cells were transfected with miR-627, resulting in significantly inhibited growth of
HCT-116 CRC cells (Padi 2013). JMJD1A, a histone demethylase which has been shown to
promote CRC growth, was predicted and confirmed as a target of miR-627 as its overexpression
results in downregulation of JMJD1A (Padi 2013).
Significant alteration of miR-145 was also found in 1,25(OH)2D3 treated gastric cancer
cells (Chang 2012). Decreased expression of miR-145 has been characterized in gastric cancer
cells when compared to normal cells (Chang 2012). miR-145 expression was shown to be
induced by 1,25(OH)2D3 treatment in a VDR dependent manner (Chang 2012). As with other
1,25(OH)2D3 induced miRNA, overexpression of miR-145 led to induction of cell cycle arrest
(Chang 2012). Two direct targets of miR-145 were identified and confirmed: E2F3 CDK6
(Chang 2012). As with other cell types, one major effect of 1,25(OH)2D3 on gastric cancer cells
is the modulation of cell cycle related genes through induction of miRNA.
Differential expression analysis of miRNA in bladder cancer cells treated with
1,25(OH)2D3 has yielded a novel miRNA expression profile (Ma 2015). Sixteen differentially
expressed miRNA were identified including miR-10a, miR-22, miR-29a, miR-30d, miR-96,
miR-125b-1, miR-126, miR-130a, miR-147, miR-147b, miR-193b, miR-335, miR-421, miR454, miR-542–5p, and miR-1237 (Ma 2015). Biological processes regulated by these miRNA
were evaluated using the PANTHER pathway analysis program and found the top three
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regulated biological processes to be: protein metabolism and modification (16%), protein
phosphorylation (11%) and MAPKKK cascade (10%) in 253J cells, and stress response (21%),
amino acid biosynthesis (15%) and sulfur metabolism (11%) in 253J-BV cells (Ma 2015). No
analysis including gene target prediction or validation was performed.
ii. Retinoic Acid
The active vitamin A metabolite retinoic acid drives neurogenesis, cardiogenesis, body
axis extension, development of the forelimb buds, foregut, and eye during embryonic
development and is essential for vertebrate cell-cell signaling pathways that control
differentiation including Wnt, TGF-β and hedgehog (Duester 2008). Modulation of miRNA
expression by retinoic acid has been demonstrated in multiple cell types including leukemia
(Garzon 2007), neural (Chen 2014) (Welch 2007) (Foley 2011) and breast cancer (Khan 2015).
Treatment of patient derived leukemia cells with all-trans-retinoic acid (ATRA), a
retinoic acid derivative, showed altered expression of nine miRNA, eight of which were
upregulated (Garzon 2007). Of these eight up-regulated miRNA, let-7a-3 and let-7b transcription
was shown to be activated via ATRA induced NFκB binding of the let-7a-3 promoter (Garzon
2007). Further, ATRA treated cell exhibited downregulation of Bcl2 and RAS genes which was
correlated to increased activation of known miRNA regulators of those proteins, let-7a and miR15a/miR-16-1, respectively (Garzon 2007).
In ATRA treated U87 MG glioma cells, differential expression of 28 miRNA was
demonstrated (Chen 2014). Of most significance was the near 10-fold upregulation of miR-302b,
which was shown to target the transcriptional regulator of glioma proliferation E2F3 (Chen
2014). Increased expression of miR-302b and subsequent repression of E2F3 expression was
associated with apoptosis in a dose-dependent manner (Chen 2014). miRNA mediated E2F3
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modulation by ATRA treatment has also been demonstrated in neuroblastoma cell lines (Welch
2007). Typically repressed in neuroblastoma, ATRA treated cells demonstrated significant
upregulation of miR-34a (Welch 2007). miR-34 was then shown to directly target E2F3,
inducing the caspase-dependent apoptotic pathway (Welch 2007).
Study of neuroblastoma cell lines treated with ATRA has also yielded insight into the
tumor suppressive role of miR-10a and miR-10b (Foley 2011). ATRA treatment of SK-N-BE,
LAN5 and SHSY-5Y cell lines led to overexpression of miR-10a/b and induced differentiation
(Foley 2011). Ectopic overexpression of miR-10a/b similarly replicated the differentiated
phenotype exhibited by the ATRA treated cells (Foley 2011). Direct targeting of nuclear receptor
corepressor 2 (NCOR2), a corepressor of gene transcription which is known to suppress neurite
outgrowth, by miR-10a/b resulted in neural cell differentiation and downstream repression of
MYCN expression (Foley 2011).
1.4.2 Essential nutrients: One-Carbon vitamins
The mechanistic link between cancer susceptibility, one-carbon vitamins and epigenetics
has been repeatedly shown to involve modulation of miRNA expression in the development of
hepatocellular carcinoma (HCC) in rat liver (Kutay 2006) (Pogribny 2008) (Tryndyak 2009)
(Starlard-Davenport 2010). This connection has also been shown in head and neck squamous cell
carcinoma (Marsit 2006) and most recently CRC (Beckett 2015).
Initial work by Kutay et al identified significant downregulation of miR-122a in rats fed a
diet low in methionine (0.18%) and devoid of choline and folic acid when compared to controls
fed the deficient diet supplemented with 0.58% L-methionine, 0.3% choline, and 2 mg/kg folic
acid (Kutay 2006). Downregulation of miR-122a expression was confirmed in primary human
HCC tissue samples (Kutay 2006). Follow up study identified downregulation of tumor
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suppressor miRNAs miR-34a, miR-16, and miR-127 (Pogribny 2008). In rats fed a methyl
deficient diet, western blot analysis revealed increased protein levels of respective gene targets
miR-34a and miR-127; E2F3 and BCL6 (Pogribny 2008). Further analysis by this group
reaffirmed downregulation of miR-34a and miR-127 in the developmental stages of HCC in rats
fed a methyl deficient diet in addition to showing aberrant expression of miR-200b and miR-16a
(Tyndyak 2008). Corresponding upregulation of gene targets E2F3, NOTCH1, Bcl-6, and Bcl-2
proteins were confirmed and related to dysregulated apoptosis as well as upregulation of
ZFHX1B, a known inducer of EMT (Tyndyak 2008). miR-155 and miR-221 were found to be
upregulated in liver cells of mice fed methyl deficient diets in a subsequent study, however no
gene targets were verified (Starland-Davenport 2010).
In a cultured cell study of lymphoblast cell line TK-6, aberrant miRNA expression
profiles in cells grown in a methyl deficient medium was found (Marsit 2006). This effect
imparted by a methyl deficient diet was reversible when adding a complete medium (Marsit
2006). Of note was significant overexpression of miR-222 in methyl deficient cells (Marsit
2006). This finding confirmed in vivo using human peripheral blood from individuals with head
and neck squamous cell carcinoma and low folate intake which showed subjects at the bottom
one percentile of dietary folate intake had significantly higher expression of miR-222 when
compared to subjects at the top one percentile (Marsit 2006).
To date, analysis of the effect of methyl deficient diets on miRNA in human CRC have
only been evaluated in a single study. Serum miR-21, folate and B12 were evaluated in a primary
case–control cohort consisting of patients with colonoscopy confirmed adenomatous colon
polyps as well as in a secondary cohort taken from a large cross-sectional cohort of 649 elderly
participants who gave blood (Beckett 2015). Folate and B12 were measured by chemiluminescent
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assay while miR-21 expression was quantified using qPCR (Beckett 2015). In the primary cohort
significant upregulation of plasma miR-21 was found in women with adenomatous polyps and
cases had significantly higher erythrocyte bound folate than controls, but not in men (Beckett
2015). miR-21 expression varied significantly with folate levels in both females and males in
both cohorts (Beckett 2015). This finding was supported using a cultured cell models showing
increased expression of miR-21 in cells treated with excess folate, even when results were
corrected for proliferation (Beckett 2015).
Previous work by our group has demonstrated combined mild depletion of one-carbon
vitamins (Liu 2007a) (Liu 2011) affects colorectal carcinogenesis. Mice fed a one-carbon
vitamin depleted diet were found to have strand breaks in the APC gene (Liu 2007a), increased
Wnt signaling, increased tumor multiplicity, increased tumor incidence and increased aberrant
crypt foci in vivo (Liu 2011). These studies effectively demonstrate a Wnt signaling mediated
role in the development of CRC associated with dietary one-carbon vitamin intake and provide
the basis for our current work.
1.4.3 Bioactive compounds
1.4.3.1 Epigallocatechin Gallate (EGCG)
The green tea polyphenol Epigallocatechin gallate (EGCG) has been shown to suppress
proliferation, invasiveness and tumor growth (Fang 2015). Microarray analysis of 328 miRNA
from EGCG treated HepG2 human hepatocellular carcinoma cells revealed aberrant expression
compared to control cells (Tsang 2010). Downregulation of 48 miRNA including oncogenic
miR-21 and upregulation of 13 miRNA including tumor suppressive miR-16 was found (Tsang
2010). Downregulation of miR-21 has also been found in EGCG treated mouse prostate tumor
tissues along with upregulation of tumor suppressive miR-330 (Siddiqui 2011).
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1.4.3.2 Resveratrol
Resveratrol (trans-3,4′,5-trihydroxystilbene), a dietary polyphenolic compound found in
plant sources such as grapes and berries has demonstrated promise for cancer treatment and
prevention in preclinical trials (Bishayee 2009). Mediation of miRNA expression by resveratrol
has been shown in several cancer cell lines (Tili 2010). Resveratrol treatment of human leukemia
cells resulted in upregulation of tumor suppressor miR-663, decreasing activity of target
activator protein-1 (AP-1) factors JunB and JunD and lipopolysaccharide endotoxins, leading to
impaired lipopolysaccharide induced upregulation of oncogenic miR-155 (Tili 2010).
Assessment of miRNA expression profiles from SW480 CRC cells treated with
resveratrol showed downregulation of 26 miRNA, including CRC-associated oncogenic miR-21
and miR-92a, and upregulation of 22 miRNA, including miR-663 (Tili 2010). Resveratrol
mediated suppression of oncogenic miRNA expression was correlated with increased protein
levels of their gene targets including Dicer1 and tumor suppressor factors PDCD4 and PTEN
(Tili 2010). Increase in miR-663 expression was associated with downregulation of key effectors
of the TGF-β pathway which is involved in cell proliferation, differentiation, migration and
apoptosis (Tili 2010).
1.4.3.2 Curcumin
Curcumin is the main bioactive compound in the spice turmeric and has been
demonstrate to have a prolific anti-cancer effect in recent years (Anand 2008) . A number of
studies show this effect may be related to altered miRNA expression induced by curcumin
treatment (Sun 2008) (Yang 2010) (Zhang 2010) (Saini 2011) (Gao 2012) (Dahmke 2013)
(Kronski 2014) (Guo 2015). All studies to date indicate curcumin induces upregulation of tumor
suppressor miRNA leading to subsequent downregulation of oncogenic targets (Sun 2008) (Yang
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2010) (Zhang 2010) (Saini 2011) (Gao 2012) (Dahmke 2013) (Kronski 2014) with some effect
exhibited on the downregulation of oncogenic miRNA (Sun 2008) (Zhang 2010) (Guo 2015).
In the initial study demonstrating this effect, Sun et al showed significant upregulation of
the miR-22 and downregulation of miR-199a-3p in xBC-3 human pancreatic cancer cells (Sun
2008). Upregulation of miR-22 was associated with suppressed expression of P1 transcription
factor (SP1) a gene associated with tumor growth and metastases and estrogen receptor 1
(ESR1), an important breast cancer target with a role in cellular responsiveness to estrogens and
antiestrogens (Sun 2008).
In breast cancer cells, curcumin related modulation of the prometatstatic and
proinflammatory cytokines CXCL1 and -2 has been shown to be controlled by upregulation of
miR-181b in MDA-MB-231 cell lines (Kronski 2014). Mediation of the anti-apoptotic factor
Bcl-2 by curcumin induced upregulation of miR-15a and miR-16 has been shown in cell lines
MCF-7, SKBR-2 and Bcap-37 when compared to controls (Yang 2010). This pair of miRNA,
miR-15a and miR-16, have also been shown to be upregulated in curcumin treated K562 and
HL-60 leukemia cells and regulate the expression of Wilms' tumor 1 (WT1) an oncogenic
transcription factor commonly upregulated in acute human leukemia and chronic myelogeous
leukemia (Gao 2012).
In addition, targeting of Bcl-2 via curcumin induced modulation of miRNA has been
shown to be exhibited in murine melanoma (Dahmke 2013). A diet consisting of 4% curcumin
was fed to C57BL/6 mice injected with murine B78H1 melanoma cells, leading to a 100-fold
increase in expression of miR-205-5p and a significant decrease in predicted targets Bcl-2 and
proliferating cell nuclear antigen (PCNA) (Dahmke 2013).
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In bladder cancer, miR-203 is frequently downregulated due to MIR203 promoter
hypermethylation (Saini 2011). Saini et al demonstrated curcumin mediated restoration of miR203 in bladder cancer cell lines, leading to inhibited proliferation, migration, invasion and
induced cell-cycle arrest, and apoptosis through targeting of the oncogenes Akt2, Src, c-jun and
survivin (Saini 2011). Interestingly, restoration of miR-203 function is believed to be mediated
through epigenetic modulation via hypomethylation of the miR-203 promoter as curcumin
inhibits DNMT1 and induces global genomic DNA hypomethylation (Saini 2013).
Downregulation of oncogenic miRNA by curcumin treatment has been demonstrated in
pancreatic (Sun 2008), andenocarcinoma (Zhang 2010) and prostate cancer cells (Guo 2015). In
the multidrug-resistant human lung adenocarcinoma cell line A549/DDP, curcumin treatment
was shown to induce cell proliferation and induce apoptosis (Zhang 2010). Further investigation
revealed this effect to be likely due to decreased expression of miR-186-3p, however no target
genes associated with this effect were established (Zhang 2010).
Most recently, the effects of curcumin on miRNA expression in prostate cancer cells has
been studied. Guo et al demonstrated curcumin treatment of PC3 cells led to downregulation of
miR-208 in a dose-dependent manner (Guo 2015). Downregulation of miR-208 led to increased
expression of its target CDKN1A, a cell cycle regulator, resulting in decreased cell proliferation
(Guo 2015).
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CHAPTER 2
PURPOSE OF THE STUDY
2.1 Overview
In the United States, Colorectal Cancer (CRC) is the third most common cancer and the
third leading cause of cancer death, resulting in the death of an estimated 26,270 men and 24,040
women in 2014 (Siegel 2014). Convincing evidence indicates Western lifestyle and diet are
critical factors for the development of CRC. Observational studies show physical inactivity,
obesity, alcohol consumption and smoking coupled with low intakes of fruits, vegetables and
whole grains, as well as high intake of red and processed meats are associated with increased risk
of this cancer (Durko 2014). However, a significant scientific gap exists in understanding the
mechanism(s) mediating this epidemiological phenomenon. Therefore, to elucidate the cellular
pathways by which environmental factors, including the critical dietary factor, mediate the
development of CRC is of vital importance to combat this prevalent disease.
CRC tumorigenesis is a multistep process that results from accumulations of a complex
series of genetic and epigenetic abnormalities under aberrant microenvironmental influence. A
vast majority (>90%) of colon cancers in humans possess over-activation of the tumorigenic Wnt
signaling pathway and there is strong evidence that this activation is pivotal in CRC
carcinogenesis (Fodde 2001). CRC is traditionally divided into sporadic (75-80%) and familial
(hereditary) cases (20 ~25%) (de la Chapelle, 2004). Among familial CRC, only ~5% are due
directly to inherited genetic mutations. Approximate 20% have a positive family history but
cannot be categorized into hereditary CRC syndrome (Al-Sohaily 2011) (Power 2010). Familial
Adenomatous Polyposis (FAP), a hereditary CRC with mutations in the APC gene within the
Wnt pathway (Kinzler, 1996), only account for a small portion (1~2% of all CRCs) (Fodde
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2001). Therefore, the large portion of aberrant Wnt signaling as described above are not due to
inherited origins and might be induced by environmental factors including diet (Narayan 2003).
The Wnt pathway is a cell signaling pathway mediated by the highly conserved Wnt
family of secretory glycoproteins. Wnt proteins signal cell proliferation (van de Wetering 2002),
polarity (Wong 1993) and fate (Miller 1996) during embryogenesis as well as regulate adult
tissue homeostasis (Reya 2003). In the canonical pathway, a Wnt ligand binds to the membranebound frizzled (Fzd) receptor and a co-receptor, low density lipoprotein receptor-related protein
6 (LRP6), allowing for transduction of the Wnt signaling pathway (Wodarz 1998). Binding of
the Wnt ligand to Fzd and Lrp6 recruits Axin to the cell membrane, resulting in the sequester of
the Axin/Apc/GSK3β destruction complex, thereby hindering β-catenin degradation and
allowing its stabilization (Clevers 2006). The β-catenin protein then translocates into the nucleus
where it associates with T cell factor/lymphoid enhancer (TCF/LEF) transcription factors
(Molenaar 1996) (Behrens 1996) activating transcription of downstream Wnt target oncogenes
such as c-Myc (He 1998), cyclin-D1 (Tetsu 1999) and c-Jun (Mann 1999).
The association between folate and CRC has been well demonstrated in epidemiological
and preclinical studies (Giovannucci, 2002) (Choi 2000) (Kim 2005). Folate is required as a
methyl donor to homocysteine for the synthesis of methionine, which derives the universal
methyl donor (S-adenosylmethionine) for DNA methylation (van den Veyver, 2002). Within this
process, other B-vitamins, such as vitamin B2, B6 and B12, also participate in the reactions as
co-factors. Deficiency in these nutrients has also been shown to result in hypomethylation in the
colon (Liu 2007). It is also demonstrated that, compared to healthy colonic epithelium, CRC
cells typically exhibit genomic hypomethylation, and conversely gene-specific promoter
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hypermethylation, which may act in transcriptional silencing of gene expression and thereby lead
to CRC (Fearon 2010).
In the recent decade, miRNAs are of particular interest in cancer research as expression
modification by miRNAs has been implicated in CRC by targeting mRNAs that encoding either
oncogenes or tumor suppressors (Slaby 2009). miRNAs may stimulate cancer proliferation by
affecting biological reactions related the development of cancer, such as cell proliferation,
evasion of growth suppression and resistance to cell death (Ross 2011). miRNAs can regulate
gene expression, but by themselves can also be regulated by epigenetic modification. miRNAs
can be regulated through promotor methylation as well as histone modifications (Liu 2014). CpG
island promoter hypermethylation in a number of miRNAs has been demonstrated to be a
hallmark of metastasis in human cancer (Lujambio 2008).
2.2 Hypothesis and Specific Aims
A prior studies from our laboratory have demonstrated the depletion of one-carbon
metabolism related B-vitamins including folate, vitamin B2, B6 and B12, so-called ‘one-carbon
vitamins’, induced a genomic DNA hypomethylation in mouse colonic epithelium, and
alterations on multiple components within the Wnt signaling pathway were identified (Liu 2007).
Extending from these observations, another study using Apc1638N intestinal cancer model coupled
with a “Wnt-reporter” mouse model (BAT-LacZ) further demonstrated that combined
inadequacies of one-carbon vitamins amplified colonic Wnt signaling indicated by elevation of
the externally inserted and β-catenin-dependent “Wnt-reporter” gene, β-galactosidase. This
reporter gene provides genuine indication of the activation of Wnt pathway. This study also
demonstrated increased intestinal tumor incidence and multiplicity consequent to the
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inadequacies of these B-vitamins and the elevated Wnt signaling (Liu 2011). Although Strand
breaks in the mutation cluster region of the APC gene was indicated as a possible target by onecarbon vitamin depletions, it does not exclude other potential mechanisms and pathways which
may also be mediated the one-carbon metabolisms given their critical roles in both biological
methylation as well as nucleotide synthesis (Liu 2007) (Liu 2011). Strikingly, recent studies
indicate that miRNAs not only possess a role in the regulation of Wnt signaling pathway (Anton
2011), but also target the one-carbon metabolism pathway (Stone 2011). Therefore, we
hypothesize in the present study that combined inadequacies of one-carbon vitamins mediates
the Wnt signaling pathway via controlling the expression of miRNAs. To test this hypothesis, we
utilized colonic epithelial samples from mice fed either a one-carbon vitamin deficient diet
(folate, riboflavin, B6 and B12 depletion) or their replete diet, and pursue the following two
specific aims:
Specific Aim #1: Using miRNA array to identify what miRNAs are altered by onecarbon vitamin depletion.
Specific Aim #2: In silico prediction of miRNA target genes within the Wnt signaling
cascade, and experimental validation of the predicted Wnt pathway-specific genes.
2.3 Significance
In this work we define relationships between dietary intake of one-carbon vitamins,
miRNAs, Wnt signaling and colorectal cancer. This provides a new lens to understand the
parthenogenesis of the disease in relation to dietary B-vitamin status. We discover a miRNA
expression profile for colorectal epithelial tissue with one-carbon vitamin depletion. This
research is the first to elucidate the effect of one-carbon vitamin deficiencies on miRNA
33

expression and presents the identification of their Wnt signaling-specific gene targets in
colorectal epithelium. An understanding of the molecular and biochemical responses produced
by one-carbon vitamin should be beneficiary to the public health via designing appropriate
dietary strategies.
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CHAPTER 3
EXPERIMENTAL DESIGN AND METHODS
Colonic samples used in this project were collected from an animal study performed in
Tufts University. The protocol was approved by the Institutional Animal Care and Use
Committee at the Jean Mayer U.S. Department of Agriculture (USDA) Human Nutrition
Research Center on Aging at Tufts University. Brief descriptions for the animals, diets, as well
as sample collections were shown below, more details regarding the experimental design can be
found in our previous publication (Liu 2011).
3.1 Animals and Sample Preparation
3.1.1 Animals and Diets
The tumorigenic model, Apc1638N, was intentionally selected to investigate the
modulation of intestinal tumorigenesis. This model possesses a mild tumorigenic phenotype
(Pretlow 2003), which is particularly useful for this type of experiment, since the very aggressive
tumorigenic phenotypes present in many of the more commonly used models, such as the Apcmin
mouse, readily overwhelm the modest effects produced by nutritional interventions. Both strains,
which are on the C57BL/6 background, were bred and cross-bred in our center. These animals
were pair-fed one of two experimental diets that contained different levels of folate and vitamin
B2, B6, and B12 (Table 1) for 16 wk beginning at 8 wk of age. The amino acid-defined diet was
originally designed to precisely govern folate status (Clifford 1989) and has been used
extensively in our previous studies (Song 2000). It is noteworthy that diets intended to induce
very mild degrees of dietary vitamin depletion were used in this study; this issue is discussed in
greater depth in our previous publication (Liu 2011).
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3.1.2 Colonocyte Isolation and Sample Preparation
After consuming the experimental diets for 16 weeks (from the age of 8 weeks to 24
weeks), all mice were anesthetized and then exsanguinated by cardiac puncture. The method for
colonocyte isolation was previously described (Bjerknes 1981) and with slight modification.
After washing with ice-cold PBS, the colon was inverted and incubated in 30 mM EDTA at 4°C
for 30 mins. The colonocyte was then scraped off gently with forceps. The muscular and
connecting tissue were discarded and the isolated colonocytes were washed with PBS. After
centrifugation, the isolated colonocyte pellets collected into 1.5 ml Eppendorf tube and frozen in
-80°C for the following DNA or RNA extraction and molecular assays.
Table 1 Concentrations of one-carbon vitamins in the experimental diet.
Riboflavin
Pyridoxine HCl
Folic acid
Treatment
B12 (µg/kg)
(mg/kg)
(mg/kg)
(mg/kg)
Folate sufficiency
6.0
7.0
5.0
2.0
(control)
Multiple vitamin
0.5
0.5
0.0
0.0
depletion (MVD)

3.2 The measurement of microRNA profile
3.2.1 Affymetrix microRNA array
miRNA expression profile analysis were performed on isolated colonic epithelial cells
from 6 Apc1638N mice fed control or MVD diets using the Affymetrix GeneChip miRNA Array v.
1.0. The GeneChip miRNA Array v. 1.0 covers 71 organisms including mouse, rat, human,
monkey, canine and others. A total of 609 mouse miRNAs were included in this Genechip.
Total RNA and miRNA extraction from tissue samples were performed using using TRIzol®
(Invitrogen, ThermoFisher Scientific). miRNA were labeled using the FlashTag Biotin HSR
labeling kit according to manufacturer’s protocol (Affymetrix, CA). First, Poly (A) tailing is
performed at 37°C for 15 minutes, subsequently followed by ligation of the FlashTag biotin
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signaling molecule, performed at room temperature for 30 minutes, before the addition of the
Stop Solution. The labeled RNA samples were then added to a hybridization mixture and
hybridized on the microarray overnight. Following hybridization, the arrays were washed and
stained using the Affymetrix Fluidics Station 450 and scanned with the Affymetrix GeneChip
Scanner 3000 7G using the Command Console software. Affymetrix miRNA QCTool were used
for quality control, with following-up statistical analysis using SAS v9.4 as described in the
statistical section.
3.2.2 Validation of microRNA array by real-time PCR.
To validate the results of Affymetrix miRNA array, we selected two miRNAs (miR21,
and miR122) whose expressions were identified by the miRNA microarray to be significantly
changed between the control and one-carbon vitamin depletion group. We also selected 3
miRNAs within the miR-29 family (miR-29a, miR-29b and miR-29c) whose expression were
detected in the Affymetrix miRNA array, but the differences between the one-carbon vitamin
depletion group and replete control group did not reach a statistically significant degree. These
three miRNAs were associated with colorectal cancer (Kapinas 2010). Moreover, the family of
miR-34, consisting of miR-34a, b and c, is known to regulate the processes of growth, apoptosis
and metastasis (Roy 2012). However, the signals for this miR-34 family were below the
detectable level in the Affymetrix microarray, we examined their expressions by real-time PCR.
For the examination of these miRNAs, the production of cDNA by reverse transcription were
performed using NCodeTM miRNA First-Strand cDNA Synthesis kit (Invitrogen, ThermoFisher
Scientific). All the miRNAs in the RNA sample (2 ug) were polyadenlyated using poly A
polymerase and ATP. Following polyadenylation, SuperScript III reverse transferase and a
specially-designed universal RT primer were used to synthesize cDNA from the tailed miRNA

37

population. Real-time PCR analysis was performed on ABI prism 7300 (Applied Biosystems)
using the SYBR Green master mix (Applied Biosystems, ThermoFisher Scientific). miRNA
detection was performed using SYBR Green. Data was normalized using the average Ct value of
two mouse housekeeper genes, sno-251 and sno-55 for miR-21, 122, 29a, 29b and 29c, whereas
the Ct value of 5s rRNA were used as control for the normalization of miR34a, 34b and 34c. The
selections of housekeeping small RNAs as controls for the normalization did not make
significant differences. The miRNA and forward primer sequences were shown on
Supplementary Table 1.
3.3 Prediction of microRNA target genes within the Wnt pathway
3.3.1 The prediction of miRNA targets by DIANA mirPath
Gene target predictions for 18 miRNAs with either significant (p<0.05) or mildly altered
expression (p<0.10) identified by Affymetrix array or Real-Time PCR was performed using the
DNA Intelligent Analysis (DIANA) miRNA pathway analysis webserver DIANA-miRPath v2.0.
This target prediction tool provides the highest sensitivity and specificity when compared to
other available miRNA target prediction tools, although this produces fewer results (Reczko
2012a). In silico miRNA target prediction is performed using the latest version of DIANAmicroT algorithm, DIANA-microT-CDS, an algorithm which computes a miRNA–gene
interaction score for predicted targets and/or experimentally verified targets derived from
DIANA-TarBase v6.0. DIANA-miRPath v2.0 allows for hierarchal clustering based on
interaction levels as well as pathway enrichment utilizing Kyoto Encyclopedia of Genes and
Genomes (KEGG) v58.1 for Mus musculus (Vlachos 2012).
DIANA-microT-CDS predicted targets were utilized as few targets have been verified
and thus using DIANA-TarBase v6.0 yielded few results. DIANA-microT-CDS has been
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updated to utilize miRBase version 18 and Ensembl version 69 target sequences from both 3′UTR and protein coding sequence (CDS) transcripts while other miRNA-gene interaction
algorithms use 3′-UTR target sites alone (Reczko 2012b). This allows for increased sensitivity as
miRNA favor target sites in the CDS in genes with short 3′-UTRs (Reczko 2012b). DIANAmicroT-CDS has been demonstrated to have the highest sensitivity at any level of specificity
when compared with other state-of-the-art miRNA-gene interaction algorithms when tested
against pulsed stable isotope labeling by amino acids in cell culture (pSILAC) proteomics data
sets (Reczko 2012a). An interaction score cut-off of 0.8 was chosen as it provides a manageable
number of predicted targets, on average 350 targets per miRNA, as well as appropriate precision
and sensitivity.
Enrichment analysis of miRNA gene targets within the Wnt pathway was performed
under the selection of KEGG pathway mmu04310. This enrichment utilizes the one-tailed
Fisher’s exact test algorithm. This algorithm was chosen as it is used to detect enriched pathways
with targets of specific miRNAs, exempting depleted pathways, is appropriate for small number
statistics, and provides exact probabilities.
3.3.2 Validation of predicted miRNA targeted genes within the Wnt pathway
Validations of 6 predicted target genes within Wnt pathway selected from the Wnt
signaling cascade: Wnts and Wnt antagonists (Wnt11, Sfrp1), Signaling transduction genes (Lrp1,
APC, β-catenin) and downstream genes (Axin 2), were performed using Real-Time PCR. Total
RNA was extracted from frozen tissue using Trizol (Invitrogen, ThermoFisher Scientific) and
purified using the RNeasy Mini Cleanup kit (Qiagen, Valencia, CA, USA). cDNA was then
synthesized with SuperScript III (Invitrogen, Carlsbad, CA, USA). Real-time PCR was
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performed on the ViiA™ 7 Real-Time PCR System (Applied Biosystems, Foster City, CA).
Primer sequences were listed in supplementary Data (Table S2).
3.4 Interaction of microRNA and Wnt pathway
Gene target prediction data was visualized using Cytoscape v3.3, an open source
bioinformatic software platform for visualizing molecular interaction networks and biological
pathways and integrating these networks with annotations, gene expression profiles and other
state data. The Wnt KEGG pathway for Mus musculus was downloaded from the KEGG pathway
database (http://www.kegg.jp/kegg/pathway.html) and imported into Cytoscape using the
KEGGscape application. Predicted miRNA-gene target interactions were then uploaded using
data generated with DIANA-miRPath v2.0.
3.5 Statistical analysis
Data are expressed as means ± SEM. Data analysis was performed using SAS (Version 9.4,
SAS Institute, Cary, NC). Comparisons between groups were made with a T-test. Significance
was accepted when p < 0.05, and a false discovery rate cutoff of q < 0.2 was used when multiple
comparisons were conducted. Heatmap was created based on transformed z-score values using R
program.
For the miRNA and Wnt pathway related expression data analysis, the expression of each
gene was normalized to the housekeeping genes, small RNAs (SnoRNA or 5s rRNA), or
GAPDH (Cttarget gene-Cthousekeeping). Statistical analyses were performed based on ΔCt. The relative
gene expression in the multiple one-carbon vitamin deplete group comparing to the replete
control group were reported as 2−ΔΔCt, where ΔΔCt=CtMVD-CtControl.
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CHAPTER 4
RESULTS
4.1 Tumor incidence and multiplicity increased in mice fed a multiple one-carbon vitamin
deficient diet
The number of tumors in the small intestine and colon, which were assessed in a blinded
fashion, was significantly different between the control group and the vitamin deplete group
(Table 2). In the control group, tumors were observed in 5 out of 10 mice, whereas 10 out of 11
mice possessed tumors in the deplete group (p = 0.064). Tumor multiplicity, which indicates the
number of tumors per mouse, was significantly greater (p = 0.028) in the deplete group than in
the controls. To limit the cost, only 8 animals per group were selected for the follow-up miRNA
assays and the tumor incidence and multiplicity of these animals were shown in the parentheses
in Table 2.

Table 2 Influences on tumorigenesis. The effect of one-carbon vitamin deficiencies
on tumor incidence (percentage of mice bearing tumors) and tumor multiplicity
(average number of tumors per mouse in each group) in Apc1638N mice.
Tumor
Tumor
Diet
Incidence
Multiplicity
5/10
0.500
CTRL
(3/8)*
(0.375)
10/11
1.364
MVD
(8/8)
(1.625)
p_value

0.064

0.028

* Numbers in the parentheses represent tumor incidence and tumor multiplicity of the mice in each
group selected for the miRNA assays. CTRL: Control; MVD: Multiple Vitamin Depletion.
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4.2 One-carbon vitamin deficiencies altered the microRNA expression profile in the colonic
epithelium
4.2.1 miRNAs identified from Affymetrix miRNA microarray
The miRNA expression profiles were measured using Affymetrix miRNA microarrays on
colonic epithelial cells from Apc1638N mice fed with one-carbon vitamin deficiencies (folate,
vitamin B2, B6 and B12) or diets sufficient in those B-vitamins. Six miRNAs (miR-30e-3p,
miR-122, miR-711, miR-541, miR-92b and miR-21) in a total of 609 examined to be
significantly altered in MVD mice (p<0.05) with additional 9 microRNAs having a mild degree
of alterations (p<0.10). The fold changes of these miRNAs were shown in Supplementary Data
(Table S3)
Following array analysis, samples were clustered according to their miRNA profile using
the R software hierarchical clustering algorithm. Hierarchical clustering analysis revealed two
distinct clusters, composing of those that are upregulated and those that are downregulated in
MVD deficient mice when compared to controls. Upregulation of 7 miRNAs (miR-21, miR-711,
miR-541, miR-30e-3p, miR-409-3p, miR-146a, miR-27a) was observed in MVD mice when
compared to controls. In comparison we observed downregulation of 8 miRNA (miR-361, miR690, miR-31, miR-92a, miR-92b, miR-139a-3p, miR-125a-5p, miR-122) in MVD mice
compared to controls (Figure 1).
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Figure 1 Differential expression of miRNA. Changes in expression levels in miRNAs were
induced by one-carbon vitamin deficiencies in Apc1638N mice when compared to controls. 15
miRNA either significantly (p<0.05) or mildly altered (p<0.10) through one-carbon vitamin
deficiencies were identified: 7 miRNAs (miR-21, miR-711, miR-541, miR-30e-3p, miR-409-3p,
miR-146a, miR-27a) were upregulated in MVD mice when compared to controls. 8 miRNA
were down regulated (miR-361, miR-690, miR-31, miR-92a, miR-92b, miR-139a-3p, miR-125a5p, miR-122) in MVD mice compared to controls. Heatmap was generated using Euclidean
measure to obtain distance matrix and complete agglomeration method for hierarchical
clustering. Green indicates upregulated expression, black indicates 0, and red indicates
downregulated expression.
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4.2.2Validation of microRNA array by real-time PCR
For the two miRNAs (miR-122, and miR-21) whose expressions were identified by the
Affymetrix miRNA microarray to be significantly changed between the control and one-carbon
vitamin depletion group, our real-time PCR validation recapitulates the microarray data, and
significant differences were identified (Figure 2). For those 3 miRNAs within the miR-29 family
(miR-29a, miR-29b and miR-29c) whose expression were detected in the Affymetrix miRNA
array, but the differences between the one-carbon vitamin depletion group and replete control
group, our real-time PCR results showed a same pattern as the Affymetrix miRNA microarray
data: the expression of all 3 miRNAs increased by the depletion of one-carbon vitamins, but the
real-time PCR detected a statistical significant increase for miR-29c (p=0.045), and a mild
degree (p=0.060) of increase for miR-29b (Figure 3). For the 3 miRNAs within the family of
miR-34 (miR-34a, miR-34b and miR-34c), the signals of which were below the detectable level
in the Affymetrix microarray, our real-time PCR results showed a significant decrease (p < 0.05)
of the miR-34c expression in the MVD group (Figure 4).
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Figure 2. Relative expression of miR-122 and miR-21 in colonic samples from mice with
and without multiple one-carbon deficiencies from real-time PCR and Affymetrix
microarray Analysis. A) Real-time PCR results. One-carbon vitamin deficiencies resulted in a
60% decrease in expression of miR-122 (p=0.027) and a 40% increase in miR-21 expression
(p=0.028). B) Affymetrix miRNA microarray results. One-carbon vitamin deficiencies decreased
expression of miR-122 by 90% (p=0.011) and increased expression of miR-21 by 50%
(p=0.042).
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Figure 3. Relative expression of the miR-29 family in colonic samples from mice with and
without multiple one-carbon deficiencies from real-time PCR and Affymetrix microarray
analysis. A) Real-time PCR results. One-carbon vitamin deficiencies resulted in increased
expression of miR-29a by 20% (not significant), miR-29b by 50% (not significant) and miR-34c
by 50% (p=0.045) B) Affymetrix miRNA microarray results. Increased expression was observed
in all miR-29 family members, however this increase was not significant.
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Figure 4. Relative expression of the miR-34 family in colonic samples from mice with and
without multiple one-carbon vitamin deficiencies from real-time PCR analysis. One-carbon
vitamin deficiencies decreased expression of miR-34c by 50% (p=0.044).

4.3 The prediction of microRNA targets within the Wnt pathway
4.3.1 Predicted miRNA target genes.
A total of 18 miRNAs, including those 15 miRNA which were shown to be either
significantly (p < 0.05) or mildly altered (p< 0.10) in the Affymetrix miRNA microarray data,
plus miR-29b, miR-29c and miR-34c identified to be significantly (p < 0.05) or mildly (p< 0.10)
by real-time PCR, were assessed for gene targets within the Wnt pathway using the DIANA
mirPath tool. A total 2,074 total predicted gene targets across 85 different pathways, of which
15 of 18 miRNA tested were shown to have a total of 40 gene targets within the Wnt pathway
(p<0.05). Of the 40 predicted genes, 26 are associated with canonical β-catenin pathway, 12 are
associated with the PCP pathway and 14 are associated with the Ca2+ pathway (Figure 5). A
detailed list of those miRNAs and their target genes within the Wnt pathway is shown in the
Supplementary data (Table S4).
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Figure 5. microRNA gene targets within the Wnt signaling pathway. 18 significantly altered
(P<0.05) or mildly altered (P<0.10) miRNA in Apc1638N mice fed a one-carbon vitamin deficient
diet are predicted to have a total of 40 gene targets within the Wnt pathway (P<0.05). Targets
were predicted using gene target sequences from both 3′-UTR and protein coding sequence in
silico using DIANA microT-CDS. KEGG pathway enrichment was performed using a one-tailed
Fisher’s exact test and corrected for false discovery rate. No Wnt signaling associated gene
targets were predicted for miR-122, miR-139 or miR-541. Three previously validated Wnt
signaling associated gene targets for miR-122 were found when using DIANA Tarbase: Camk2b,
Ccnd1 and Smad4. 14 miRNA are shown in fuchsia, targeting is shown by red arrows, predicted
gene targets are shown in yellow.
4.3.2 Validation of the microRNA predicted genes within the Wnt pathway
To experimentally validate the in silico predicted miRNA target genes, we measured 6
target genes selected from the Wnt signaling cascade: Wnts and Wnt antagonists (Wnt11, Sfrp1),
Signaling transduction genes (Lrp1, APC, β-catenin) and downstream genes (Axin2) with real48

time PCR using the ViAATM 7 PCR system (Applied Biosystems, Carlsbad, CA). Our results
showed that one-carbon vitamin deficiencies elevated the expressions of β-catenin (p < 0.05) and
increased the expression of the Wnt pathway downstream gene, Axin2, to a less degree (p =
0.054). We also observed, the expression of SFRP1 was inhibited (p < 0.05). The overall
expressions of the Wnt pathway-specific target genes examined altered in a fashion indicating the
activation of Wnt signaling (Figure 6).

Figure 6. Relative Expression of miRNA target genes within the Wnt signaling cascade
associated in colonic samples from mice with and without multiple one-carbon vitamin
deficiencies determined by real-time PCR. One-carbon deficiencies increased expression of βcatenin and Axin2 4.4-folds (p < 0.05) and 2.5 folds (p=0.054) respectively, whereas decreased
the expression of SFRP1 by 2.9 folds (p < 0.05) (Control n=8 mice; MVD n=8 mice).
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CHAPTER 5
DISCUSSION
Over the past decade, the functions of miRNAs have been intensively investigated, and it
is well-accepted now that miRNA regulate a variety of biological processes including
development, metabolism, cell differentiation, proliferation and apoptosis, and thereby contribute
to nearly all types of diseases including cancer (Jiang 2009). Our prior studies demonstrated the
depletion of one-carbon metabolism related B-vitamins, including folate, riboflavin, vitamin B6
and B12, induced a genomic DNA hypomethylation and an elevation of the tumorigenic Wnt
signaling in mouse colonic epithelium. The present study showed that the combined
inadequacies of those one-carbon vitamins alters the expressions of a number of miRNAs, and an
in silico bioinformatic analysis indicated that multiple components within the Wnt signaling
cascade are targeted by those miRNAs identified. These findings indicate that miRNAs may
constitute a mechanism by which one-carbon B-vitamin depletions regulate the Wnt signaling
pathway and thereby inform intestinal tumorigenesis.
In this study, using the miRNA microarray (GeneChip miRNA Array v. 1.0, Affymetrix)
which contained 609 mouse miRNAs, 208 miRNAs were detected in at least 4 samples out of the
total of 6 samples examined. Among these miRNAs, we identified 6 miRNAs (miR-30e-3p,
miR-122, miR-711, miR-541, miR-92b and miR-21) to be significantly altered in the B-vitamin
deplete group (p < 0.05) with additional 9 miRNAs having a mild degree of alterations (p <
0.10), indicating that only ~3% miRNAs were significantly altered by one-carbon vitamin
depletions with additional ~4% miRNAs altered in a mild degree. Though the total percentage of
miRNAs identified to be altered is not high, the data is consistent with prior studies which also
showed a methyl deficient diet altered 1~7% miRNAs in liver (Kutay 2006) (Tryndyak 2009)
(Dolganiuc 2009).
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To validate the miRNA microarray data, we performed real-time PCR individually for 2
miRNAs (miR-21 and miR-122) which were identified to be significantly altered by the
microarray, 3 miRNAs (miR-29a, miR-29b, and miR-29c) whose signals were detectable in the
microarray, but not significantly different between the B-vitamin deplete and replete groups, and
3 miRNAs (miR-34a, miR-34b, and miR-34c) whose signals were not detectable in the array.
Consistent with the microarray data, significant differences were detected for miR-21 and miR122 by real-time PCR. For the miR-29 family, our real-time PCR measurement showed a similar
pattern with the microarray data, but the differences between the dietary treatments reached to be
significant or mildly significant for miR-29c (p = 0.045) and miR-29b (p = 0.060). For miR-34
family, the real-time PCR identified the expression of miR-34c was significantly downregulated
by one-carbon vitamin depletion (p = 0.044). We performed real-time PCR on 8 samples per
group rather than 3 samples per group for the microarrays, and the sample size increased the
power to statistically identify the differences. Nevertheless, new miRNAs continue to be defined
and up to date there are 1915 mature miRNAs are discovered (www.miRBase.org, access on
March 18, 2016). It should be expected that there are more miRNAs whose expressions may be
regulated by one-carbon vitamins.
Here we present a novel miRNA expression profile for murine colonic epithelial tissue in
animals fed a one-carbon vitamin deficient diet. Interestingly we find significant upregulation of
miR-21 in both microarray and PCR analysis. When compared to other miRNA, miR-21 has
been studied with notable depth, particularly as an oncogene in CRC.

miR-21 has been

established as a reliable prognostic marker (Kjaer-Frifeldt 2012) (Zhang 2013), is a significant
predictor of survival (Nielsen 2011) and has multiple validated tumor suppressor gene targets in
CRC (Allgayer 2009) (Wang 2009e) (Cottonham 2010) (Chang 2011) (Yu 2011) (Ferraro 2014).
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Wnt associated gene target prediction for miR-21 conferred predicted homology for a single
gene, Dkk2. In vitro expression of Dkk2 has previously been shown to be significantly
downregulated by overexpression miR-21 human tongue cancer cell line SCC25 (Kawakita
2014).
Another miRNA identified by both microarray and real-time PCR is miR-122. However,
our in silico prediction did not find any targets within the Wnt pathway for miR-122. Target
prediction using DIANA microT-CDS which utilizes 3’-UTR and protein coding sequence data
from miRBase version 18 and Ensembl version 69 to generate a miRNA-gene target interaction
score yielded zero results. This was particularly surprising as current research suggests miR-122
acts as a tumor suppressor through direct targeting of the Wnt ligand (Xu 2012) (Wang 2014a).
In both glioma (Wang 2014a) and hepatocellular carcinoma miR-122 (Xu 2012) has been shown
to directly target Wnt1 with an identified target binding site in the 3’-UTR. This result is not
limited to DIANA microT-CDS; other well established tools such as Targetscan v7.0
(http://www.targetscan.org/) and miRanda (http://www.microrna.org/microrna) did not predict
Wnt1 as a top 1000 targets either (data not shown). However, target prediction using DIANA
Tarbase v6.0, which utilizes verified gene targets, yielded three genes: Camk2b, Ccnd1 and
Smad4 but did not include Wnt1 (data not shown). These findings suggest there are limitations to
the use of in silico miRNA gene target prediction tools, even when gene targets have been
previously verified.
With the limitations of in silico miRNA gene target prediction in mind, we
experimentally validated 6 genes selected from sections of the Wnt signaling cascade: Wnts/Wnts
antagonists, signaling transduction genes, and downstream genes. Our results showed that the
expression of Sfrp1 was inhibited (p < 0.05). Sfrp1, a Wnt signaling antagonist, has been
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previously shown to be downregulated in CRC (Caldwell 2006), which is agreement with our
speculation that one-carbon vitamin depletions upregulated Wnt signaling and thereby contribute
to intestinal tumorigenesis. Another component which was experimentally validated is β-catenin,
the accumulation and stabilization of which is critical in canonical Wnt signaling activation
(Klaus 2008). Axin2, a downstream indicator of Wnt signaling, was marginally elevated (p =
0.054) in the one-carbon vitamin deficient group. The expression change of the remaining 3
genes were not experimentally validated. However, it is noteworthy that the expression changes
of these genes by those B-vitamin depletion exhibit a pattern indicating the activation of Wnt
signaling; the inhibition of Sfrp1, the Wnt antagonist, the elevation of β-catenin, a Wnt signaling
transduction key component, and the mildly increased expression of Axin2, a downstream
indicator of Wnt signaling.

53

CHAPTER 6
CONCLUSIONS
Overall, this study provides novel insight into the mechanisms of dietary modulation of
colorectal cancer with a focus on one-carbon metabolism related vitamins driving alterations of
miRNA expression which thereby regulate the tumorigenic Wnt pathway. By implementing a
combinatorial approach to quantify in vivo differential expression of miRNAs through both
microarray and Real-time PCR, and in silico prediction of miRNA targets, we demonstrated that
the combined inadequacies of one-carbon vitamins including folate, riboflavin, vitamin B6 and
B12 is sufficient to induce differential expression of miRNAs, which in consequence posttranscriptionally regulate genes within the Wnt signaling pathway.
This study presents a miRNA expression profile showing 18 miRNAs found to be either
significantly (p < 0.05) or mildly (p < 0.10) differentially expressed in the colonic epithelium of
mice fed the depleted diet when compared to the counterpart. In silico prediction of the targets of
those 18 miRNAs identified 40 genes within the Wnt pathway to have homology with miRNA
seed sequences within their 3’-UTR or protein coding sequence. Of the 6 genes tested for
experimentally target validation, the expression of Sfrp1 was shown to be significantly inhibited
(p < 0.05) whereas β-catenin was shown to be significantly elevated (p < 0.05) with alterations of
others in a fashion indicating the activation of Wnt signaling. These findings indicate that
miRNAs may constitute a mechanism by which one-carbon B-vitamin depletions regulate the
Wnt signaling pathway and thereby induce intestinal tumorigenesis. In summary, this study sheds
light on the molecular mechanisms by which inadequate intake of folate and other metabolically
related B vitamins modulate colorectal cancer risk, and provides novel insights into the practice
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of colorectal cancer prevention by dietary management of one-carbon metabolism related
vitamins.
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